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OBJECTIVE: To describe morbidity associated to varicella in children attending day care centers.
METHODS: Descriptive study carried out through inquiries with parents of 664 children who acquired varicella after admission
to day care centers in Taubaté (population: 244,165, census of 2004), a prosperous city in the State of São Paulo.
RESULTS: The median age was 36 months (range 6 to 80 months); 8.4% of the children had varicella before 1 year of age. The
main symptoms were: exanthema (100.0%), fever (85.4%) anorexia (39.6%), and headache (15.3%). 517 children (77.9%) had at
least 1 medical visit, and 80.6% received at least 1 medication; 73 (11.0%) received nonsteroidal antiinflammatory drugs, and 52
(7.8%) received antibiotics. Complications occurred in 38 children (5.7%; 95% confidence interval: 3% - 8%); 8 (1.2%) were
hospitalized, and 5 (0.7%) had sequelae. Complications and hospitalizations rates were 3 times more frequent in children with
less than 1 year of age than in older children. More than half of the children and of the working parents were absent from their
regular activities for more than a week. CONCLUSIONS: Varicella was associated with significant morbidity, affected younger
children, was complicated in more than 5%, and left sequelae in 0.7% of children. More than 10% of the children received
nonsteroidal antiinflammatory drugs, highlighting the need to warn the population about the risks of these drugs. Although varicella
vaccination is not recommended for children younger than 12 months, vaccination of the children older than a year could avoid by
herd immunity the transmission to babies. Brazilian public health authorities should be alerted to this issue and offer varicella
vaccine to children attending day care centers.
KEYWORDS: Varicella-zoster/complications. Children. Day care centers. Nonsteroidal antiinflammatory drugs.
INTRODUCTION
Varicella is an acute viral disease of global distribu-
tion.¹,² The primary infection results in the appearance of
papulovesicular, polymorphic exanthematic lesions of cen-
tral distribution, while the reactivation of the virus results
in herpes-zoster. In previously healthy children, the disease
is acute, self-limited, and rarely causes death; however, re-
cent studies have showed that children attending day care
centers are a risk group for varicella complications.3-5
Since 1997, a varicella vaccine has been licensed in
Brazil and is recommended to children, but this vaccine is
not included in the routine vaccination program. In order
to establish public policies for varicella immunization, it
is necessary to investigate the impact of the disease in the
community.5-10
At the beginning of the 1990s, varicella was considered
the main cause of death by diseases that could be prevented
by immunization in the United States,11 Canada,8,10 Ger-
many,9 and the United Kingdom.12 In Brazil, there are only
few studies about varicella complications in healthy chil-
dren.3–5,13–16 Data from the Health and Hygiene Department
of Sao Paulo City show that children attending day care
centers have the disease earlier and present higher rates of
complications and death than other children.5
In the city of Taubaté (population: 244,165, census of
2004), a survey conducted by the University Hospital re-
vealed that in the last 5 years, the annual rate of hospitali-
148
CLINICS 2006;61(2):147-52Varicella zoster in children attending day care centers
Marcitelli R, Bricks LF
zation due to varicella and its complications was 3.7 per
100,000 children under 12 years of age, which is similar
to that in the United States, (2.7 – 4.2/100,000/year) in
prevaccination times.17
Among all the exanthematic diseases, varicella is the
easiest to identify by lay people,10 enabling viable data col-
lection about the disease through population inquiries.18,19
For these reasons, we consider it appropriate to describe
the illness morbidity in children attending day care centers.
METHODS
Design
Descriptive study, carried out through inquiry with par-
ents of children that acquired varicella after enrollment in
day care centers, from June, 2002 to February, 2003.
After the approval by the Committee on Ethics and Re-
search, this study was presented to the Education and Cul-
ture Department of Taubaté, and the interviews with par-
ents and adults responsible for the children with positive
antecedent to varicella were planned.
Setting and study population
Taubaté is located in São Paulo State (Brazil), having
an estimated population of 244,165 inhabitants, with 41,512
people under the age of 10. Approximately 10,000 children,
with ages ranging from 6 months to 7 years, are enrolled
in the 44 municipal day care centers (public and subcon-
tracted) distributed 1 per district throughout the city.20 Most
of children attending these day care centers are from low-
income families. Using the program Statcalc, software Epi-
Info, version 6.04,21 it was estimated that it would be nec-
essary to collect information about the antecedents of vari-
cella in 1,200 children in order to collect data referring to
500 children who had actually contracted the disease after
admission to the day care centers. The appraisal of the sam-
ple size was based upon the estimated prevalence of vari-
cella complications in previously healthy children (5%),
with a variation of 5% and confidence interval (CI) of 95%.
It was estimated that half of the children enrolled in day
care centers had not yet acquired the disease and data loss
was estimated to be 20% of the sample.
The 44 day care centers were numbered and then ran-
domly sampled to get the information about the anteced-
ents of the disease. The first 8 day care centers sampled,
totaling 1,370 children were chosen for the study. Their dis-
tribution within the city was homogeneous.The study was
conducted in 2002.
Only children with positive antecedents to varicella
were selected for the study; their parents were interviewed,
and vaccination records were verified by one of the authors
(RM). All data were compiled in a database using the soft-
ware, Epi-info version 6.04.21
Statistical analysis
The statistical analysis was descriptive, and the results
expressed in simple frequencies are shown in the tables with
the average and 95% confidence interval.
Data from the standard questionnaire containing infor-
mation about the children was entered into a computer and
analyzed by the statistics program, Epi-info 6.04. Analy-
sis of variables was performed by using the Mantel-
Haenszel χ² test. Risk was calculated (OR and CI 95%) for
the following variables: age of the child with varicella with
complication, hospitalization, groups of children under 12
months and above 1 year of age; absent time from the
centers and work, and presence of complications. The vari-
able averages were compared using Student’s t test, and a
P value <0.05 was considered significant.
RESULTS
The day care centers sampled are listed on Table 1. Out
of the total 1,370 children attending at the sampled day care
centers, 541 (39.5%) were excluded due to a negative an-
tecedent to varicella; of the 829 (60.5%) with positive an-
tecedent for varicella, 106 (12.8% of positives) were ex-
cluded for having presented varicella before admission to
day care centers or when on vacation. Out of the eligible
723 cases, 59 (8.2% of the elligibles) were supplementary
excluded for lack of informed consent or absence of par-
ents for the interview after 3 invitations, leaving a final
sample of 664 (91.8% of the elligibles) who were included
in the study,
Mothers were the main source of information (86.0%).
Demographic characteristics and the health conditions of
the studied population are summarized on Table 2. The
median age of enrolled children was 36 months (range: 6
mo to 7 yr; std dev = 17.3 mo), without difference between
genders.
Among the 73 children (10.9%) with some base disease,
57 (8.6%) had respiratory allergy, 10 (1.5%) antecedents
of repetition respiratory diseases; and 5 (0.8%) had epi-
lepsy. No children had used corticosteroids.
The morbidity of the disease was associated with clini-
cal signs and symptoms, presence of complication, hospi-
talization, and sequelae (Table 3). Fever was present in
85.4% of the cases and persisted for more than 3 days in
20.2% of the children. The most prescribed medicines were
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antipyretics, used by 540 children (81.3%); NSAIDs by 73
children (11.0%), and of these, 35 (47.9%) received aspi-
rin. Antibiotics were prescribed to 52 children (7.8%), but
half of the parents weren’t able to point out the reason for
antibiotic use. No children received acyclovir or varicella
zoster immunoglobulin.
Varicella complications occurred in 38 children (5.7%),
and bacterial infections were the most frequent (Table 4).
Eight children (1.2%) were hospitalized for 3 to 22 days
(median, 8.5 days) and 5 (0.7%) had sequelae. The aver-
age age of the hospitalized children was 33.6 months, but
children younger than 12 months showed a higher risk of
complication (14.3%), as compared to the 5.7% for other
ages (Odds Ratio = 2.9; CI 95%: 1.2 – 7.0). The chance
of hospitalization was also higher for infants (3.5% versus
1.2 %), however, without statistical significance (OR = 3.6;
CI 95%: 0.5 – 20.5).
Five hundred and seventeen children (77.9%) had medi-
cal visits, and of these, 145 (28.1%) were evaluated more
than once; 392 children (59.1%) were kept away from the
centers, and of these, 263 (67.2%) stayed off for more than
a week. Three hundred and forty-eight parents (53.1%)
were absent from their activities, and of these, 195 (56%)
stayed off for more than 7 days.
Children with varicella complications had more pro-
longed fever (>3 days), a higher number of medical evalu-
ations, were absent from the day care centers for more days
(OR = 2.12; CI 95% 1.02 – 4.4), and their parents missed
more days of work. Nonsteroidal antiinflamatory drug use
was also significantly associated with the presence of vari-
cella complications (P < 0.001).
DISCUSSION
More than 60% of the children enrolled in day care
centers in Taubaté had positive antecedents for varicella.
Even though this information was not confirmed by sero-
logical tests, several studies on children have shown that
Table 4 - Varicella complications.
Type of varicella complications  n %
Bacterial skins infections (impetigo, abscess, cellulite) 31 81.5
Pneumonia 3 7.9
Sepsis 2 5.3
Otitis / sinusitis 2 5.3
Total 38 100.0
Table 3 - Morbidity associated with varicella
Characters and complications Presence  n  %
Exanthema Yes 664 100.0
No 0 0.0
Fever Yes 567 85.4
No 97 14.6
Anorexia Yes 263 39.7
No 401 60.3
Headache Yes 101 15.2
No 563 84.8
Illness duration (days) ≤ 7 449 67.0
> 7 215 33.0
Drug use Yes 540 81.3
No 124 18.7
Complications Yes 38 5.7
No 626 94.3
Hospitalization Yes 8 1.2
No 656 98.8
Sequelae Yes 5 0.7
No 659 99.3
Table 1 - Number (n) and proportion (%) of children by institution, clinical history of varicella, and enrolled in this study
Children enrolled Children with positive antecedent to varicella Children included
Day care center in institution Total After admission to day in this study
n (%) n (%) care center n (%) n (%)
1 272 (19.9) 168 (20.3) 147 (20.3) 137 (20.6)
2 186 (13.5) 118 (14.3) 102 (14.1) 95 (14.3)
3 114 (8.3) 99 (11.8) 83 (11.9) 78 (11.8)
4 103 (7.5) 69 (8.3) 61 (8.5) 55 (8.3)
5 70 (5.4) 46 (5.7) 37 (5.2) 35 (5.3)
6 263 (19.0) 148 (17.8) 133 (18.4) 122 (18.3)
7 176 (12.9) 87 (10.5) 71 (9.9) 68 (10.2)
8 186 (13.5) 94 (11.3) 84 (11.7) 74 (11.2)
Total 1370 (100.0) 829 (100.0) 723 (100.0) 664(100.0)
Table 2 - Characteristics of children attending day care
centers with positive antecedent to varicella
Characteristics n %
Age < 12 months 56 8.4
≥ 1 year of age 608 91.6
Sex Male 331 49.9
Female 333 50.1
Comorbidity Yes 73 10.9
No 591 89.1
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the diagnostic positive value for the antecedents of vari-
cella is high when compared to the serological tests.18,19,22
In this study, the median age of children with positive
antecedents to varicella was 3 years; in studies carried out
in the U.S., the median age of children was 5.2 years.2,3 In a
study previously carried out in the State of São Paulo, Bra-
zil, it was found that children attending day care centers were
infected by varicella earlier than the children brought up at
home.4 In this study, the incidence of varicella in younger
children probably was related to precocity of contact with
varicella. The rate of secondary attacks by varicella is about
90%.4,10,11,23–26 In secondary cases of varicella, children are
exposed to a higher viral charge and show a higher number
of skin lesions and higher rates of complications.15,25
In this study, a total of 56 children (8.4%) had varicella
before 1 year of age; a higher percentage than that found
in Italy (2.9%)27 and Spain (6.9%).7 It is important to em-
phasize that infants with varicella are a high-risk group for
complications, hospitalization, and death associated with
varicella.4,10,11 In this study, children younger than 1 year
had about 3 times more complications and hospitalization
than the children older than 1 year.
The morbidity associated with varicella can be assessed
according to different aspects, such as: frequency of sig-
nals and symptoms, duration of symptoms, complication
rate, hospitalization, squelae, and death rate.
The symptoms usually described in this population were
similar to the ones found in the literature.1,2,23 In 20% of
the cases, parents reported that the child had fever for more
than 3 days, and more than one third of the parents reported
that the disease lasted more than a week, particularly for
children with complications.
Bias of information may have been a limiting factor in
analyzing the results of this study, because parents’ infor-
mation was collected, on average, 11 months (range, 15
days to 29 months) after the disease. The information about
antibiotic use (7.8%) reveals that probably more than 5%
of children had complications. In Spain, in a prospective
study about varicella, the rate of complications was 12%,
and more than 5% of children had otitis media or sinusitis
after varicella.6 In this study, these complications were re-
ported by only 2 parents (0.2%).
Information bias is more probable for mild symptoms,
duration of the disease, treatment, and time of day care and
work absenteeism than for more serious problems, such as
complications, hospitalizations, and permanent sequelae.
So, one of the most important findings of this study is re-
lated to the high risk of complications in infants less than
1 year of age attending day care centers, probably related
to precocious exposure to other children in an crowded en-
vironment.
The social impact of varicella is associated with absen-
teeism of children and their parents from their daily rou-
tines. As many mothers did not work, a little more than
50% of those who did work outside the home had to be
absent from their activities to take care of their children.
Because most parents of these children were of low school
level and income and because many were unemployed or
underemployed, it was not possible to evaluate the social
costs associated with varicella in this study.
No children included in this study received acyclovir
or specific immunoglobulin (VZIG). In Brazil, these medi-
cations are usually prescribed to immunocompromised chil-
dren; in other countries these medicines are more frequently
used in healthy children.1,2,5,11,23 All children enrolled in this
study were previously healthy.
Fever was one of the main symptoms associated with
varicella, and antipyretics were the most commonly pre-
scribed medicines. Even though the use of nosteroidal
intinflammatory drugs is contraindicated to children with
varicella; 35 children received these drugs.1, 9,11,28,29
The complications related to varicella depend on age
and the immunologic condition of the individual.10,24,29 In
this study, complications occurred in 5.7% of children, and
the most frequent complications were bacterial skin infec-
tions (80%) similar to the ones found in the United States,23
and Canada.10 Epidemiological studies carried out in Eu-
rope revealed that the complication rates for varicella were
of 3.5% to 5% in Italy, 2% in France, and 13.2% in Spain.6,7
These differences are probably related to the different meth-
ods employed in the analysis of the study data. In a pro-
spective study recently published and carried out in Spain,
the complication rate of varicella was higher than 10%.6
This result strongly suggests that in retrospective studies
the complication rates are underestimated.
Although the vaccine against varicella does not prevent
all cases of the disease, it is estimated that it can prevent
more than 95% of the most serious complications. Unfor-
tunately, in Brazil, the vaccine against varicella is not avail-
able in the public health system for previously healthy chil-
dren, and none of the children included in this study had
been vaccinated against varicella. Most of the parents of
these children have no information about the benefits of
varicella vaccination.
Compared with older children, infants younger than 1
year of age were 3 times more likely to have complica-
tions and hospitalization associated with varicella. Although
varicella vaccine is not recommended for children less than
1 year of age, after 1995, when it was added to the US
schedule of immunization, herd immunity resulted in a sig-
nificant reduction in morbidity and mortality associated
with varicella, even in children less than 1 year of age.30–32
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The rate of hospitalization because of varicella com-
plications was 1.2%, comparable to that reported for
Canada and the United States (0.2% – 1.5%) before the in-
troduction of routine vaccination against varicella.8,10 In the
United States, more than 90% of the secondary infections,
two thirds of the hospitalizations, and half of the deaths
occur in previously healthy children;11 the same happened
in Canada10 and in Europe.7 All children enrolled in this
study were previously healthy. These data support the
recommendations to include varicella vaccine for all eli-
gible children.
More than two thirds of the children had at least 1 medi-
cal visit; children with varicella complications had on
average 1.5 consultations. These results were similar to
those found in Canada,10 France,7 and Spain.6
More than 50% of the children were kept away from
the centers for more than a week. If the time of absenteeism
was not overestimated by the parents, this period of time
can be considered excessive, because the transmission of
varicella is very low after the fifth day of the exan-
thema.4,10,11
CONCLUSION
Children enrolled in day care centers acquired varicella
precociously (median, 36 mo); infants younger than 12
months of age had a high risk of varicella complications
and hospitalization, 3 times higher when compared to the
children older than a year.
Varicella was associated with significant morbidity and
rates of complications (5.7%), hospitalization (1.2%), and
sequelae (0.7%).
More than 10% of the children were treated with nons-
teroidal anti-inflammatory drugs, which highlights the need
to warn the population about the inherent risks of using
these drugs in children.
It is important to establish a surveillance system to
closely monitor the impact of varicella to children attend-
ing day care centers. Brazilian public health authorities
should be alert to this issue and we hope this study may
be taken as a strong exhortation for official health services
to offer varicella immunization to children attending day
care centers.
RESUMO
Marcitelli R, Bricks LF. Varicela-zóster em crianças que
frequentam creches. Clinics. 2005; 61(2):147-52.
OBJETIVO: Descrever a morbidade associada à varicela
nas crianças usuárias de creches.
MÉTODOS: Estudo descritivo, realizado através de
inquérito com pais ou responsáveis por 664 crianças que
contraíram varicela após admissão às creches Municipais
de Taubaté, SP.
RESULTADOS: A mediana de idade das crianças
acometidas por varicela foi de 36 meses (6 meses a 7 anos);
8,4% tiveram a doença antes dos 12 meses. As principais
manifestações foram: exantema (100,0%), febre (85,4%),
anorexia (39,6%) e cefaléia (15,3%). Quinhentas e dezessete
crianças (77,9%) tiveram pelo menos uma avaliação médica,
80,6% receberam algum tipo de medicamento; 73 (11,0%)
receberam antiinflamatórios não-hormonais e 52 (7,8%)
receberam antibióticos. Trinta e oito crianças (5,7%) tiveram
complicações (intervalo de confiança de 95%: 3 – 8%), oito
(1,2%) foram hospitalizadas e cinco (0,7%) ficaram com
seqüelas. Em comparação com crianças com mais de um
ano, as menores de um ano apresentaram risco 3 vezes maior
para complicações e hospitalizações. Mais da metade das
crianças e dos pais que trabalhavam ficou mais de uma
semana afastada de suas atividades.
CONCLUSÕES: A varicela acometeu crianças de baixa
idade, causou complicações em mais de 5% e deixou
seqüelas em 0,7% dos casos. Mais de 10% das crianças
foram tratadas com antiinflamatórios não-hormonais, sendo
necessário esclarecer a população sobre os riscos do uso
desses fármacos. As autoridades de saúde deveriam estar
atentas a essa questão e oferecer a vacina às crianças
matriculadas em creches.
UNITERMOS: Varicela-zóster. Complicações. Crianças.
Creches. Antiinflamatórios não hormonais.
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